Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

Brent DA.

Depress Anxiety. 2009;26(10):871-4. doi: 10.1002/da.20617. No abstract available.

PMID:
19798756
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Benefits exceed risks of newer antidepressant medications in youth--maybe.

March JS, Vitiello B.

Clin Pharmacol Ther. 2009 Oct;86(4):355-7. doi: 10.1038/clpt.2009.172. No abstract available.

PMID:
19763113
[PubMed - indexed for MEDLINE]
3.

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS, Kendall PC.

N Engl J Med. 2008 Dec 25;359(26):2753-66. doi: 10.1056/NEJMoa0804633. Epub 2008 Oct 30. Erratum in: N Engl J Med. 2013 Jan 31;368(5):490.

PMID:
18974308
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Flexibility within fidelity.

Kendall PC, Gosch E, Furr JM, Sood E.

J Am Acad Child Adolesc Psychiatry. 2008 Sep;47(9):987-93. doi: 10.1097/CHI.0b013e31817eed2f. No abstract available.

PMID:
18714195
[PubMed - indexed for MEDLINE]
5.

Evidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents.

Silverman WK, Pina AA, Viswesvaran C.

J Clin Child Adolesc Psychol. 2008 Jan;37(1):105-30. doi: 10.1080/15374410701817907. Review.

PMID:
18444055
[PubMed - indexed for MEDLINE]
6.

Cognitive-behavioral therapy for anxiety disordered youth: a randomized clinical trial evaluating child and family modalities.

Kendall PC, Hudson JL, Gosch E, Flannery-Schroeder E, Suveg C.

J Consult Clin Psychol. 2008 Apr;76(2):282-97. doi: 10.1037/0022-006X.76.2.282.

PMID:
18377124
[PubMed - indexed for MEDLINE]
7.

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, DeBar L, McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Melhem N, Porta G, Onorato M, Zelazny J.

JAMA. 2008 Feb 27;299(8):901-13. doi: 10.1001/jama.299.8.901.

PMID:
18314433
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Pharmacotherapy for social phobia, generalised anxiety disorder and separation anxiety disorder in children and adolescents: an overview].

Dieleman GC, Ferdinand RF.

Tijdschr Psychiatr. 2008;50(1):43-53. Review. Dutch.

PMID:
18188828
[PubMed - indexed for MEDLINE]
Free Article
9.

SET-C versus fluoxetine in the treatment of childhood social phobia.

Beidel DC, Turner SM, Sallee FR, Ammerman RT, Crosby LA, Pathak S.

J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1622-32.

PMID:
18030084
[PubMed - indexed for MEDLINE]
10.

A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.

March JS, Entusah AR, Rynn M, Albano AM, Tourian KA.

Biol Psychiatry. 2007 Nov 15;62(10):1149-54. Epub 2007 Jun 5.

PMID:
17553467
[PubMed - indexed for MEDLINE]
11.

Costs of nine common mental disorders: implications for curative and preventive psychiatry.

Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A.

J Ment Health Policy Econ. 2006 Dec;9(4):193-200.

PMID:
17200596
[PubMed - indexed for MEDLINE]
12.

Increasing minority research participation through community organization outreach.

Alvarez RA, Vasquez E, Mayorga CC, Feaster DJ, Mitrani VB.

West J Nurs Res. 2006 Aug;28(5):541-60; discussion 561-3. Review.

PMID:
16829637
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Cognitive behavioural therapy for anxiety disorders in children and adolescents.

James A, Soler A, Weatherall R.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004690. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD004690.

PMID:
16235374
[PubMed - indexed for MEDLINE]
14.

The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity.

Costello EJ, Egger HL, Angold A.

Child Adolesc Psychiatr Clin N Am. 2005 Oct;14(4):631-48, vii. Review.

PMID:
16171696
[PubMed - indexed for MEDLINE]
15.

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE.

Arch Gen Psychiatry. 2005 Jun;62(6):593-602. Erratum in: Arch Gen Psychiatry. 2005 Jul;62(7):768. Merikangas, Kathleen R [added].

PMID:
15939837
[PubMed - indexed for MEDLINE]
16.

Authors of TADS study reply to letter raising concerns.

March JS; TADS Group.

BMJ. 2005 Mar 26;330(7493):730-1. No abstract available.

PMID:
15790648
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team.

JAMA. 2004 Aug 18;292(7):807-20.

PMID:
15315995
[PubMed - indexed for MEDLINE]
19.

Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review.

Compton SN, March JS, Brent D, Albano AM 5th, Weersing R, Curry J.

J Am Acad Child Adolesc Psychiatry. 2004 Aug;43(8):930-59. Review.

PMID:
15266189
[PubMed - indexed for MEDLINE]
20.

Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up.

Kendall PC, Safford S, Flannery-Schroeder E, Webb A.

J Consult Clin Psychol. 2004 Apr;72(2):276-87.

PMID:
15065961
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk